Doug Ingram
Chief Executive Officer
Replay available
Sarepta Therapeutics, Inc. (SRPT) Q3 2025 Earnings Call
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) Q3 2025 earnings conference call, held 2025-11-03. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Louise Rodino-Claypack
President & Chief Medical Officer
Patrick Moss
Chief Commercial Officer
Ryan Wong
Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Sarepta Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.196 The press release and slides are available on the investor section of our website at 00:00:04.196 -- 00:00:05.818 serepta.com, 00:00:05.818 -- 00:00:10.544 and our 10Q will be filed with the Securities and Exchange Commission on Thursday after 00:00:10.544 -- 00:00:14.729 market. Joining us on the call today are Doug Ingram, Dr. 00:00:14.729 -- 00:00:20.796 Louise Rodino-Claypack, Patrick Moss, Ian Estepan, and Ryan Wong. 00:00:20.796 -- 00:00:24.661 After our formal remarks, we'll open the call for Q&A. 00:00:24.661 -- 00:00:28.966 I'd like to note that during this call, we will be making a number of forward-looking 00:00:28.966 -- 00:00:33.581 statements. Please refer to slide two on the webcast, which contains our forward-looking 00:00:33.581 -- 00:00:38.306 statements. These forward-looking statements involve risks and uncertainties, many of 00:00:38.306 -- 00:00:43.192 which are beyond disruptive control. Actual results can materially differ from these 00:00:43.192 -- 00:00:47.657 forward-looking statements, and any such risks can materially and adversely affect the 00:00:47.657 -- 00:00:52.622 business, the results of operations, and trading prices for disruptive common stock. 00:00:52.622 -- 00:00:57.156 For a detailed description of applicable risks and uncertainties, We encourage you to 00:00:57.156 -- 00:01:00.559 review the company's most recent SEC filings. 00:01:00.559 -- 00:01:04.543 The company does not undertake any obligations to publicly update its forward-looking 00:01:04.543 -- 00:01:09.748 statements, including any financial projections provided today based on subsequent events 00:01:09.748 -- 00:01:11.870 or circumstances. 00:01:11.870 -- 00:01:16.455 As noted on slide three, we will discuss non-GAAP financial...